BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10352918)

  • 1. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks.
    Solomon CG
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):247-63. PubMed ID: 10352918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of diagnosing the polycystic ovary syndrome.
    Lobo RA; Carmina E
    Ann Intern Med; 2000 Jun; 132(12):989-93. PubMed ID: 10858183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of obesity in the development of polycystic ovary syndrome.
    Motta AB
    Curr Pharm Des; 2012; 18(17):2482-91. PubMed ID: 22376149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term complications of polycystic ovary syndrome (PCOS).
    Peigné M; Dewailly D
    Ann Endocrinol (Paris); 2014 Sep; 75(4):194-9. PubMed ID: 25156132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome and metabolic syndrome.
    Ali AT
    Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
    Lo JC; Feigenbaum SL; Yang J; Pressman AR; Selby JV; Go AS
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1357-63. PubMed ID: 16434451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.
    Behboudi-Gandevani S; Ramezani Tehrani F; Hosseinpanah F; Khalili D; Cheraghi L; Kazemijaliseh H; Azizi F
    Fertil Steril; 2018 Dec; 110(7):1377-1386. PubMed ID: 30503137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic consequences of polycystic ovary syndrome.
    Churchill SJ; Wang ET; Pisarska MD
    Minerva Ginecol; 2015 Dec; 67(6):545-55. PubMed ID: 26372304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P; Raingeard I; Renard E; Bringer J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic risks in PCOS: a review of the current state of knowledge.
    Kakoly NS; Moran LJ; Teede HJ; Joham AE
    Expert Rev Endocrinol Metab; 2019 Jan; 14(1):23-33. PubMed ID: 30556433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome.
    Azziz R; Carmina E; Chen Z; Dunaif A; Laven JS; Legro RS; Lizneva D; Natterson-Horowtiz B; Teede HJ; Yildiz BO
    Nat Rev Dis Primers; 2016 Aug; 2():16057. PubMed ID: 27510637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.
    Lambrinoudaki I
    Maturitas; 2011 Jan; 68(1):13-6. PubMed ID: 20943333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
    Teede HJ; Meyer C; Norman RJ
    Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical implications of polycystic ovary syndrome].
    Dravecká I
    Vnitr Lek; 2016; 62(5):392-7. PubMed ID: 27319232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.